News

The new service is based on an 80-gene signature that identifies the basal-like, luminal-like, and HER2 molecular subtypes in breast cancer tumors. MammaPrint is the breast cancer recurrence

Reportedly, the agreement gives Novartis exclusive rights to Morphogenesis’ proprietary canine and feline cancer cell lines as well as its patented cancer vaccine technology. Morphogenesis and Novartis will

The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant’s operation for an extended period and

Derived from Novozymes Biopharma’s proprietary yeast expression technology, Recombumin is the animal-free, commercially available recombinant human albumin used in the manufacture of licensed and developmental human therapeutics. Novozymes

PPD said that the center augments its scientific and biologics drug development expertise with facilities, processes and instrumentation to help clients realise the scientific standards for their programs

Reportedly, the study enrolled 271 subjects with neuropathic pain caused by underlying diabetes into a 2-week placebo run-in period. Following this, 162 subjects were enrolled into a 13-week,

The Phase 2b trial is a randomized, open-label, multi-center, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every four weeks plus daily ribavirin

Bausch + Lomb said that the bottle’s design and development was made possible through a partnership with Amcor Rigid Plastics, a producer of PET packaging and R&D/Leverage, known

The Advia systems offer a complete HIV screening test menu allowing clinical laboratories in Europe to further consolidate infectious disease testing with other routine immunoassays. Siemens said that